Arsenic trioxide drug eluting stent - Beijing AmsinoMed Medical Device Co

Drug Profile

Arsenic trioxide drug eluting stent - Beijing AmsinoMed Medical Device Co

Alternative Names: Arsenic trioxide degradable coating stent; AVI

Latest Information Update: 25 Jun 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Beijing AmsinoMed Medical Device Co
  • Class Anti-inflammatories; Antineoplastics; Arsenicals; Ischaemic heart disorder therapies; Oxides; Small molecules
  • Mechanism of Action Endothelial cell modulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery disease; Coronary artery restenosis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 Aug 2013 Beijing AmsinoMed Medical Device initiates the phase IV PERFECT-II trial for Coronary artery disease in China (NCT02133287)
  • 01 Jul 2013 Launched for Coronary artery disease in China (Intracoronary, Implant)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top